Skip to content

Treatment effectiveness of triamcinolone oral paste and amlexanox oral paste in oral lichen planus

Comparative efficacy of topical amlexanox 5% oral paste and triamcinolone acetonide 0.1% oromucosal paste in the treatment of oral lichen planus – a randomized control trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10134012
Enrollment
30
Registered
2023-04-25
Start date
2022-01-10
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral lichen planus Oral Health Lichen planus

Interventions

30 patients with oral lichen planus were included in the study. After clinical diagnosis and histopathological confirmation, the selected patients were divided into two groups – group A and group B, t

Sponsors

D.Y. Patil University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with oral lichen planus 2. Age range 18 to 70 years

Exclusion criteria

Exclusion criteria: 1. Patients with a history of malignancy, immunocompromised diseases, metabolic diseases, pregnancy or breastfeeding, systemic viral infections, other red and white lesions 2. Undergoing systemic therapy that may interfere with disease prognosis 3. Active therapy for oral lichen planus 4. Known allergies to the study drugs

Design outcomes

Primary

MeasureTime frame
Size of the lesion measured using self-modified Thongprasom sign scoring system for oral lichen planus, at baseline (day 0) and days 15, 30 and 45

Secondary

MeasureTime frame
1. Pain intensity measured using the visual analogue score (VAS) at baseline (day 0) and days 15, 30 and 45 2. Clinical erythema measured using Clinician Erythema Assessment grading scale at baseline (day 0) and days 15, 30 and 45 2. Incidence of adverse drug reactions (if reported) during the treatment course 3. Quality of life assessed using the Chronic Oral Mucosal disease questionnaire (COMDQ) after treatment completion

Countries

India

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026